4.4 Article

Costs and Prescribing Patterns of Anthelmintics in the United States Military: A Retrospective Analysis

期刊

OPEN FORUM INFECTIOUS DISEASES
卷 9, 期 3, 页码 -

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofac040

关键词

helminth infections; anthelmintic medications; drug pricing; pinworm infection; albendazole

资金

  1. National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]
  2. Defense Health Program, US Department of Defense [HU0001190002]
  3. Infectious Disease Clinical Research Program (IDCRP) [IDCRP-097]

向作者/读者索取更多资源

The recent price increases in anthelmintic medications have had significant impacts on the costs borne by the US government for treating parasitic infections. There is a substantial number of anthelmintic prescriptions in the US military health care system annually, suggesting a higher number of helminth infections than previously thought.
Background Recent price increases in medications used to treat helminth infections have had demonstrated impacts on Medicaid and immigrant patient populations. Helminth infections are common within the US military; however, anthelmintic prescribing patterns and costs have not yet been investigated in this patient population. Methods We conducted a retrospective analysis of pharmaceutical data from the Military Health System Data Repository between fiscal years 2012 and 2019. Prescription information, including costs and demographics, were abstracted for all anthelmintic medications as well as associated helminth diagnostic codes within 30 days of the prescription dispensing date. Results On average, there were 10( )871 anthelmintic medications prescribed per year, for a total of 86( )697 during the study period. Ivermectin and albendazole were each prescribed >34( )000 times. There were 15( )498 mebendazole prescriptions and 1327 praziquantel prescriptions. The total cost of all anthelmintic prescriptions was $16( )018( )381. Annual costs for anthelmintic medications increased 16-fold during the study period, up to nearly $5( )000( )000 in fiscal year 2019, primarily driven by price increases in albendazole and mebendazole. Albendazole prescriptions accounted for $12( )282( )891 of total costs (76.7%), though only 39.1% of total prescriptions. The most common diagnosis associated with albendazole and mebendazole prescriptions was enterobiasis. Conclusions Price increases in anthelmintic medications have significantly impacted the costs borne by the US government for treating parasitic infections. There are a substantial number of anthelmintic prescriptions in the US military health care system annually, suggesting a higher number of helminth infections than previously thought.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据